Decline depth
-59.9%
From rolling 252-day high of $12.46, 219d ago.
Past the 40% Red List threshold.
-59.9%
from rolling 252-day high of $12.46 set 2025-10-21 · 219d ago
Current
$5.00
Decline depth
-59.9%
Decline σ
4.5σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since tracking began
$NERV has been tracked since 2026-03-01. It was down 44.6% from its 52-week high then — now down -59.9%.
That's 20.3 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
NERV qualifies for the Red List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.5σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (5.33% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about NERV.
NERV qualifies for the Red List on decline depth — down -59.9% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.
Cross-confirmation: decline sigma also reads 4.5σ over 20 bars.
52-week range
52W low $1.35
32.9% of range
52W high $12.46
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
88
Red List
47
Amber
59
Watch
-35.8%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to NERV
Red List
PODD
Insulet Corporation
Red ListRecovering
CLPT
ClearPoint Neuro Inc.
Red ListRecovering
PRCT
PROCEPT BioRobotics Corporation
Red ListRecovering
SRPT
Sarepta Therapeutics, Inc.
Red List
CERT
Certara, Inc.
Red List
ZBIO
Zenas BioPharma, Inc.
Questions about NERV
What people ask.
Why is NERV on Broken Stocks?
NERV qualifies for the Red List on decline depth. It is down -59.9% from its rolling 252-day high of $12.46, set on 2025-10-21 — 219d ago.
Is NERV a falling knife?
Not by the strict technical definition. NERV is down -59.9% from its 52-week high, but that high was set 219d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. NERV is still on the Red List for decline depth, but the freshness component of a falling knife is missing.
Is NERV a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is NERV trading inside its 52-week range?
At $5.00, NERV sits 32.9% of the way from its 52-week low ($1.35) to its 52-week high ($12.46). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has NERV been declining?
The current 59.9% decline accrued over 219d, which annualizes to roughly -99.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does NERV compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — NERV's decline is deeper than the sector median.